Buspirone Hydrochloride Tablet
Product Images NDC 51655-511

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Buspirone Hydrochloride (NDC 51655-511). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 511 52)

Label (51655 511 52)
Packaging label for Buspirone Hydrochloride Tablets USP 7.5 mg, containing 30 tablets. The label indicates the product is prescription only, with storage instructions to keep at 25°C (77°F) with allowed excursions to 15°-30°C (59°-86°F), and to store in the original container out of reach of children. The labeler is Northwind Health Company, LLC.*
FDA Label Image

Dosage Table (Buspirone Fig 1)

Dosage Table (Buspirone Fig 1)
Instructional chart showing how to break 15 mg or 30 mg tablets of Buspirone Hydrochloride to achieve various dosages. The left side illustrates breaking a 15 mg tablet into halves, thirds, and the full tablet for doses of 7.5 mg, 5 mg, 10 mg, and 15 mg. The right side shows similar breakage options for a 30 mg tablet to achieve doses of 8 mg, 10 mg, 15 mg, 20 mg, and 30 mg.*
FDA Label Image

Quadrisect Photo (Buspirone Fig 2)

Quadrisect Photo (Buspirone Fig 2)
Illustrations showing how to split Buspirone Hydrochloride tablets by hand. The first panel demonstrates splitting a 15 mg tablet, and the second panel shows splitting a 30 mg tablet. Each image depicts hands holding and breaking the tablet orally.*
FDA Label Image

Buspirone Structural Formula (Buspirone Str)

Buspirone Structural Formula (Buspirone Str)
Chemical structure of Buspirone Hydrochloride showing its molecular framework with labeled amide, piperazine, and pyrimidine rings, including the hydrochloride (HCl) component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.